HEL 92.1.7 In Vitro (3)H-thymidine Incorporation Assay (Cell Proliferation)

CAT#: ITS-1122-YF1482
Target Cell Organism: Human
Target Cell Name: HEL 92.1.7
Assay Type: Cell Viability/Cytotoxicity and Antiproliferative Assays
Assay Overview
This assay is to provide HEL 92.1.7-based In Vitro (3)H-thymidine Incorporation Assay (Cell Proliferation) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
HEL 92.1.7
Target Cell Organism
Human
Target Cell Background
HEL 92.1.7 is a erythroblast cell line isolated from the bone marrow of a 30-year-old, White, male patient with erthroleukemia. This cell line can be used in immune system disorder research and immunology research.
Related Diseases
Erythroleukemia
Research Area
Oncology
Assay Name
In Vitro (3)H-thymidine Incorporation Assay (Cell Proliferation)
Short Description
HEL 92.1.7-cell based In Vitro (3)H-thymidine Incorporation Assay (Cell Proliferation)
Assay Description
The 3H-thymidine incorporation assay is one such assay that can detect newly synthesized DNA in cells. Cultured cells are mixed with 3H-thymidine (radioactive) and kept for a desired incubation period. Newly replicated DNA strands can incorporate 3H-thymidine during mitosis. A scintillation counter is necessary to detect the output. Direct measurement of proliferating cells is the main advantage of this assay. However, use of harmful radioactive substances and need of special equipment are considered as main disadvantages.
Assay Type
Cell Viability/Cytotoxicity and Antiproliferative Assays
Assay Type Details
Uncontrolled proliferation is one of the main features of cancer cells. Cell-based in vitro assays are employed to determine whether test molecules possess direct cytotoxic/antiproliferative effects in cancer cells.
Assay Subtype
Cell Proliferation Assay
Assay MOA
Cell-based Assays Based on DNA Synthesis
For Research Use Only | Not For Clinical Use
Online Inquiry